In the same study, the authors reported that NSCLC cells expressing GOLPH3 at high level injected into the tail vein of a mouse model presented higher metastatic capabilities than GOLPH3-silenced cells. The gene discussed is GOLPH3; the disease is non-small cell lung carcinoma.